Will a cheaper diabetes pill match the original?
NCT ID NCT07763964
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial asks whether a generic extended-release tablet containing sitagliptin and metformin works the same as the brand-name version (Janumet XR) in healthy adults. Each participant takes a single dose of both medications at different times, and blood tests compare how the body absorbs them. The goal is to confirm the generic is bioequivalent, meaning it delivers the same amount of drug into the bloodstream.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sitagliptin/metformin
- What this could lead to
- If the generic tablet proves equivalent, it could offer a more affordable option for managing type 2 diabetes.
- What could go wrong
- This is a small, early-stage bioequivalence study in healthy volunteers, not a test of long-term safety or effectiveness in patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALANCE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Axis Clinicals Latina, S.A. de C.V.
Mexico City, 07870, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Will a cheaper diabetes pill match the original?
- Will a cheaper diabetes pill match the original?
- Generic tamsulosin put to the test: will it match the brand?
- Healthy volunteers test generic vs. brand drug equivalence
- Progesterone showdown: are two injections equally effective?
- Generic diabetes pill matches brand in healthy volunteer test